Dear readers! We present to your attention the final issue of the LOGISTICS journal in 2024. We have tried to make it rich and interesting. Today, many Russian companies operate under strict sanctions restrictions, which force them to reorient logistics flows. One of the possible solutions to this problem may be the Russia – Mongolia – China economic corridor. Details can be found in the article by Alexandra Kazunina.
Dear readers! We present to your attention the 11th issue of the LOGISTICS magazine, where you will find relevant materials and articles. And again, the focus is on international cooperation. An important event in this area was the International Trade Day 2024 Forum, held on November 7, 2024 in Moscow.
Dear readers! The tenth issue of LOGISTICS journal opens with a large article dedicated to the results of the BRICS Business Forum, held on October 18, 2024 in Moscow. Yulia Kislova, Director of Agency Market Guide LLC and publisher of LOGISTICS journal, attended the event and prepared an article where she paid special attention to international trade and logistical connectivity of the countries of the association. The details are in the room.
CV PROTEK (Protek Group) has been ranked first among the largest distributors for the 1-2 quarters of 2018, prepared by DSM Group marketing agency.
The company’s market share, according to the DSM data, was equal to 16.5% (in value terms- 109.3 billion rubles). Katren with market share of 16.5% is at the second place. While shares of two distributors in percentage terms are equal, Katren’s share in value termsis equal to 108.9 billion rubles. Puls (14.1%) is at the third position of the rating.
Distributors rating for the 1HY 2018
Rank |
Distributor |
Amount, billion rubles |
Dynamics |
Share |
1 |
Protek |
109.3 |
-5.2% |
16.5% |
2 |
Katren |
108.9 |
-0.4% |
16.5% |
3 |
Puls |
93.4 |
18.0% |
14.1% |
4 |
SIA |
29.7 |
-10.4% |
4.5% |
5 |
Pharmcomplect |
29.5 |
2.0% |
4.5% |
6 |
R-Pharm |
29.1 |
-15.4% |
4.4% |
7 |
Grand Capital |
26.5 |
46.0% |
4.0% |
8 |
BSS |
25.1 |
19.8% |
3.8% |
9 |
Profit-med |
21.2 |
47.4% |
3.2% |
10 |
Avesta Pharmaceuticals |
11.6 |
46.0% |
1.8% |